Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: Open-End Fund
  • Objective: Growth Large Cap
  • Asset Class: Equity
  • Geographic Focus: U.S.

AllianceBernstein Growth Funds - AllianceBernstein Large-Cap Growth Fund

+ Add to Watchlist

ALLIX:US

39.65 USD 0.41 1.04%

As of 20:00:00 ET on 01/29/2015.

Snapshot for AllianceBernstein Growth Funds - AllianceBernstein Large-Cap Growth Fund (ALLIX)

Year To Date: +0.03% 3-Month: +4.28% 3-Year: +19.65% 52-Week Range: 32.87 - 40.22
1-Month: -1.42% 1-Year: +18.73% 5-Year: +16.73% Beta vs RIY: 0.97

Mutual Fund Chart for ALLIX

No chart data available.
  • ALLIX:US 39.65
  • 1M
  • 1Y
Interactive ALLIX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ALLIX

AllianceBernstein Large Cap Growth Fund Inc is an open-end fund incorporated in the USA. The Fund's objective is long-term growth of capital. The Fund invests predominantly in equity securities of a limited number of large, carefully selected, high-quality U.S. companies that are judged likely to achieve superior earnings growth.

Inception Date: 03-01-2005 Telephone: 1-800-227-4618
Managers: JOHN FOGARTY / FRANK V CARUSO
Web Site: www.alliancebernstein.com

Fundamentals for ALLIX

NAV (on 2015-01-29) 39.65
Assets (M) (on 2015-01-29) 2,196.20
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for ALLIX

No dividends reported

Fees & Expenses for ALLIX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.75
Redemption Fee 0.00
12b1 Fee 0.00
Expense Ratio 0.90

Top Fund Holdings for ALLIX

Filing Date: 11/30/2014
Name Position Value % of Total
Apple Inc 1,096,034 130,351,324 5.896%
Visa Inc 345,490 89,202,063 4.035%
Allergan Inc/United States 364,578 77,979,588 3.527%
CVS Health Corp 811,630 74,150,517 3.354%
Monster Beverage Corp 581,490 65,214,104 2.950%
Gilead Sciences Inc 633,120 63,514,598 2.873%
Philip Morris International In 722,419 62,799,884 2.840%
Biogen Idec Inc 188,798 58,091,257 2.627%
Danaher Corp 654,717 54,708,153 2.474%
UnitedHealth Group Inc 546,412 53,892,616 2.438%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil